Simulataneous transdermal extraction of glucose and lactate from human subjects by reverse iontophoresis

International Journal of Nanomedicine

Volumn 3, Issue 2, 2008, Pages 211-223

  Ching, Tak S ^a   Connolly, Patricia ^b  

^a ASIA UNIVERSITY   (Taiwan)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Diagnostic monitoring; Glucose; Iontophoresis; Lactate; Transdermal

Indexed keywords

GLUCOSE; LACTIC ACID;

ARTICLE; BIOSENSOR; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIFFUSION; ELECTRODERMAL RESPONSE; EXTRACTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSDERMAL EXTRACTION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IONTOPHORESIS; LACTATE BLOOD LEVEL; LACTATE TRANSDERMAL EXTRACTION; MALE; NON INVASIVE PROCEDURE; REVERSE IONTOPHORESIS; SKIN ELECTRODE; SKIN PERMEABILITY; WAVEFORM; ADULT; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; SKIN;

ADULT; FEMALE; GLUCOSE; HUMANS; IONTOPHORESIS; LACTIC ACID; MALE; SKIN;

EID: 51649118913     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Abramson D, Scalea TM, Hitchcock R, et al. 1993. Lactate clearance and survival following injury. J Trauma, 35:584-9.
2. Amos AF, McCarty DJ, Zimmet P. 1997. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med, 14(Suppl 5):S1-S85.
3. Artru F, Jourdan C, Perret-Liaudet A, et al. 1998. Low brain tissue oxygen pressure: incidence and corrective therapies. Neurol Res, 20(Suppl 1): S48-S51.
4. Bakker J, Coffernils M, Leon M, et al. 1991. Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. Chest, 99:956-62.
5. Banga AK, Chein YW. 1998. Iontophoretic delivery of drugs: Fundamentals, developments and biomedical applications. J Control Release, 7:1-24.
6. Bell DSH. 1994. Stroke in the diabetic patient. Diabetes Care, 17:213-19.
7. de Boer J, Potthoff H, Mulder PO, et al. 1994. Lactate monitoring with subcutaneous microdialysis in patients with shock: a pilot study. Circ Shock, 43: 57-63.
8. Brancati FL, Whelton PL, Randall BL, et al. 1997. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA, 278:2069-74.
9. Burnette RR, Ongpipattanakul B. 1987. Characterization of the perm selective properties of excised human skin during iontophoresis. J Pharm Sci US, 76:765-73.
10. Cairns CB, Moore FA, Haenel JB, et al. 1997. Evidence for early supply independent mitochondrial dysfunction in patients developing multiple organ failure after trauma. J Trauma, 42:532-6.
11. Carrier M, Trudelle S, Thai P, et al. 1998. Ischemic threshold during cold blood cardioplegic arrest: monitoring with tissue pH and pO2. J Cardiovasc Surg (Torino), 39:593-7.
12. Chien YW, Siddiqui O, Sun Y, et al. 1987. Transdermal iontophoretic delivery of therapeutic peptides/proteins. I: Insulin. Ann N Y Acad Sci, 507:32-51.
13. Chien YW, Lelawongs P, Siddiqui O, et al. 1990. Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices. J Control Release, 13(2-3):263-78.
14. Ching CTS, Camilleri I, Connolly P. 2005. A low-cost, programmable device for versatile current delivery in iontophoresis applications. Sensor Actuat B-Chem, 106:534-40.
15. Connolly P, Cotton C, Morin F. 2002. Opportunities at the skin interface for continuous patient monitoring: A reverse iontophoresis model tested on lactate and glucose. IEEE Trans Nanobioscience, 1:37-41.
16. Davis BL, Kuznicki J, Praveen SS, et al. 2004. Lower-extremity amputations in patients with diabetes: pre- and post-surgical decisions related to successfiul rehabilitation. Diabetes Metab Res Rev, 20(Suppl 1): S45-S50.
17. Degim IT, Ilbasmis S, Dundaroz R, et al. 2003. Reverse iontophoresis: a non-invasive technique for measuring blood urea level. Pediatr Nephrol, 18:1032-7.
18. Delgado-Charro MB, Guy RH. 1994. Characterization of convective solvent flow during iontophoresis. Pharm Res, 11:929-35.
19. Elia S, Liu P, Hilgenberg A, et al. 1991. Coronary haemodynamics and myocardial metabolism during weaning from mechanical ventilation in cardiac surgical patients. Can J Anaesth, 38:564-71.
20. Evans J. 1995. Causes of blindness and partial sight in England and Wales 1990-1991. HMSO.
21. Gersh BJ, Anderson JL. 1993. Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm - paradoxic or predictable? Circulation, 88:296-306.
22. Guy RH, Kalia YN, Delgado-Charro MB, et al. 2000. Iontophoresis: electrorepulsion and electroosmosis. J Control Release, 64(1-3): 129-32.
23. Habicht JM, Wolff T, Langemann H, et al. 1998. Intraoperative and post-operative microdialysis measurement of the human heart - feasibility and initial results. Swiss Surg, (Suppl 2):26-30.
24. Hildingsson U, Sellden H, Ungerstedt U, et al. 1996. Microdialysis for metabolic monitoring in neonates after surgery. Acta Paediatr, 85:589-94.
25. Hirvonen J, Hueber F, Guy RH. 1995. Current profile regulates iontophoretic delivery of amino acids across the skin. J Control Release, 37:239-49.
26. Howard JP, Drake TR, Kellogg DL. 1995. Effects of alternating current iontophoresis on drug delivery. Arch Phys Med Rehabil, 76:463-6.
27. [IDF] International Diabetes Federation. 2003. Diabetes Atlas 2003, 2nd edition. Brussels: International Diabetes Federation.
28. King H, Rewers M. 1993. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care, 16:157-77.
29. Laing SP, Swerdlow AJ, Slater SD, et al. 1999a. The British Diabetic Association Cohort Study, I: all-cause mortality in patients with insulin-treated diabetes mellitus. Diabet Med, 16:459-65.
30. Laing SP, Swerdlow AJ, Slater SD, et al. 1999b. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med, 16:466-71.
31. Ledger PW. 1992. Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Deliver Rev, 9(2-3):289-307.
32. Levraut J, Ciebiera JP, Chave S, et al. 1998. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med, 157(4 Pt 1):1021-6.
33. Marecaux G, Pinsky MR, Dupont E, et al. 1996. Blood lactate levels are better prognostic indictors than TNF and IL-6 levels in patients with septic shock. Intens Care Med, 22:404-8.
34. Mendelowitsch A, Mergner GW, Shuaib A, et al. 1998. Cortical brain microdialysis and temperature monitoring during hypothermic circulatory arrest in humans. J Neurol Neurosurg Psychiatry, 64:611-18.
35. Menzel M, Doppenberg EM, Zauner A, et al. 1999. Increased inspired oxygen concentration as a factor in improved brain tissue oxygenation and tissue lactate levels after severe human head injury. J Neurosurg, 91:1-10.
36. Merino V, Kalia YN, Guy RH. 1997. Transdermal therapy and diagnosis by iontophoresis. Trends Biotechnol, 15:288-290.
37. Merino V, Lopez A, Hochstrasser D, et al. 1999. Noninvasive sampling of phenylalanine by reverse iontophoresis. J Control Release, 61(1-2):65-9.
38. Mize NK, Buttery M, Daddona P, et al. 1997. Reverse iontophoresis: monitoring prostaglandin E2 associated with cutaneous inflammation in vivo. Exp Dermatol, 6:298-302.
39. Moomey Jr CB, Melton SM, Croce MA, et al. 1999. Prognostic value of blood lactate, base deficit, and oxygenderived variables in an LD50 model of penetrating trauma. Crit Care Med, 27:154-61.
40. Murray MJ, Gonze MD, Nowak LR, et al. 1994. Serum D(-)-lactate levels as an aid to diagnosing acute intestinal ischemia. Am J Surg, 167:575-8.
41. Numajiri S, Sugibayashi K, Morimoto Y. 1993. Non-invasive sampling of lactic acid ions by iontophoresis using chloride ion in the body as an internal standard. J Pharm Biomed Anal, 11:903-9.
42. Pickup J. 2003. Diabetic control and its measurements, In: Pickup JC, Williams G (Eds.). Textbook of Diabetes, 3rd ed. Oxford: Blackwell, pp. 34.1-34.17.
43. Pikal MJ, Shah S. 1990. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes. Pharm Res, 7:222-9.
44. Pikal MJ. 2001. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev, 46(1-3):281-305.
45. Pitzer KR, Desai S, Dunn T, et al. 2001. Detection of hypoglycaemia with the Gluco Watch biographer. Diabetes Care, 24:881-5.
46. Potts RO, Tamada JA, Tierney MJ. 2002. Glucose monitoring by reverse iontophoresis. Diabetes Metab Res Rev, 18(Suppl 1)S49-S53.
47. Rao G, Glikfeld P, Guy RH. 1993. Reverse iontophoresis: Development of a noninvasive approach for glucose monitoring. Pharm Res, 10:1751-5.
48. Rao G, Guy RH, Glikfeld P, et al. 1995. Reverse iontophoresis: Noninvasive glucose monitoring in vivo in human. Pharm Res, 12:1869-73.
49. Rasmussen I, Hillered L, Ungerstedt U, et al. 1994. Detection of liver ischemia using microdialysis during experimental peritonitis in pigs. Shock, 1:60-6.
50. Rojdmark J, Blomqvist L, Malm M, et al. 1998. Metabolism in myocutaneous flaps studied by in situ microdialysis. Scand J Plast Reconstr Surg Hand Surg, 32:27-34.
51. Santi P, Guy RH. 1996. Reverse iontophoresis - parameters determining electroosmotic flow. I. PH and ionic strength. J Control Release, 38(2-3):159-65.
52. Sieg A, Guy RH, Delgado-Charro MB. 2004. Simultaneous extraction of urea and glucose by reverse iontophoresis in vivo. Pharm Res, 21:1805-10.
53. Sieg A, Guy RH, Delgado-Charro MB. 2004b. Noninvasive glucose monitoring by reverse iontophoresis in vivo: Application of the internal standard concept. Clin Chem, 50:1383-90.
54. Slomovitz BM, Lavery RF, Tortella BJ, et al. 1998. Validation of a hand-held lactate device in determination of blood lactate in critically injured patients. Crit Care Med, 26:1523-8.
55. Stephenson JM, Kenny S, Stevens LK, et al. 1995. Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes. Diabet Med, 12:149-55.
56. Tamada JA, Garg S, Jovanovic L, et al. 1999. Noninvasive glucose monitoring: Comprehensive clinical results. JAMA, 282:1839-44.
57. Tierney MJ, Tamada JA, Potts RO, et al. Cygnus Research Team. 2001. Clinical evaluation of the Gluco Watch® biographer: a continual, noninvasive glucose monitor for patients with diabetes. Biosens Bioelectron, 16(9-12):621-9.
58. The Diabetes Research in Children Network (DirecNet) Study Group. 2004. Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: Experience of the Diabetes Research in Children Network. Diabetes Care, 27:722-6.
59. The UK Prospective Diabetes Study Group (UKPDS) Group. 1998a. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352:837-53.
60. The UK Prospective Diabetes Study Group (UKPDS) Group. 1998b. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet, 352:854-65.
61. The UK Prospective Diabetes Study Group. 1998c. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ, 317:713-20.
62. The UK Prospective Diabetes Study Group. 1998d. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 317:703-13.
63. Tomohira Y, Machida Y, Onishi H, et al. 1997. Iontophoretic transdermal absorption of insulin and calcitonin in rats with newly-devised switching technique and addition of urea. Int J Pharm, 155:231-9.
64. Valadka AB, Goodman JC, Gopinath SP, et al. 1998. Comparison of brain tissue oxygen tension to microdialysis-based measures of cerebral ischemia in fatally head-injured humans. J Neurotrauma, 15:509-19.
65. Vincent JL. 1996. End-points of resuscitation: arterial blood pressure, oxygen delivery, blood lactate, or...? Intensive Care Med, 22:3-5.
66. Vincent JL. 1998. Blood lactate levels: index of tissue oxygenation. Int J Intensive Care, 5:48-53.
67. Volpe G, Moscone D, Compagnone D, et al. 1995. In vivo continuous monitoring of L-lactate coupling subcutaneous microdialysis and an electrochemical biocell. Sensor Actual B-Chem, 24(1-3):138-41.
68. Wang SL, Head J, Stevens L, et al. 1996. Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The World Health Organization Multinational Study of Vascular Disease in Diabetes. Diabetes Care, 19:305-12.
69. Westgren M, Kruger K, Ek S, et al. 1998. Lactate compared with pH analysis at fetal scalp blood sampling: a prospective randomised study. Br J Obstet Gynaecol, 105:29-33.
70. Westgren M, Kublickas M, Kruger K. 1999. Role of lactate measurements during labor. Obstet Gynecol Surv, 54:43-8.
71. Wild S, Roglic G, Green A, et al. 2004. Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27:1047-53.
72. Zauner A, Doppenberg E, Soukup J, et al. 1998. Extended neuromonitoring: new therapeutic opportunities? Neurol Res, 20(Suppl 1):S85-S90.